- Home
- ASYS vs BCAB Comparison
ASYS vs BCAB Comparison
Compare ASYS & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- BCAB
- Stock Information
- Founded
- ASYS 1981
- BCAB 2007
- Country
- ASYS United States
- BCAB United States
- Employees
- ASYS N/A
- BCAB N/A
- Industry
- ASYS Industrial Machinery/Components
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- ASYS Technology
- BCAB Health Care
- Exchange
- ASYS Nasdaq
- BCAB Nasdaq
- Market Cap
- ASYS 89.7M
- BCAB 96.2M
- IPO Year
- ASYS N/A
- BCAB 2020
- Fundamental
- Price
- ASYS $5.62
- BCAB $2.08
- Analyst Decision
- ASYS Hold
- BCAB Strong Buy
- Analyst Count
- ASYS 1
- BCAB 2
- Target Price
- ASYS N/A
- BCAB $6.00
- AVG Volume (30 Days)
- ASYS 34.5K
- BCAB 1.6M
- Earning Date
- ASYS 12-04-2024
- BCAB 11-08-2024
- Dividend Yield
- ASYS N/A
- BCAB N/A
- EPS Growth
- ASYS N/A
- BCAB N/A
- EPS
- ASYS N/A
- BCAB N/A
- Revenue
- ASYS $104,809,000.00
- BCAB N/A
- Revenue This Year
- ASYS N/A
- BCAB N/A
- Revenue Next Year
- ASYS $10.86
- BCAB N/A
- P/E Ratio
- ASYS N/A
- BCAB N/A
- Revenue Growth
- ASYS N/A
- BCAB N/A
- 52 Week Low
- ASYS $3.37
- BCAB $1.14
- 52 Week High
- ASYS $8.11
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- ASYS 46.57
- BCAB 55.80
- Support Level
- ASYS $5.59
- BCAB $1.87
- Resistance Level
- ASYS $5.98
- BCAB $2.13
- Average True Range (ATR)
- ASYS 0.25
- BCAB 0.12
- MACD
- ASYS 0.02
- BCAB 0.00
- Stochastic Oscillator
- ASYS 43.75
- BCAB 68.90
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; Semiconductor; it designs, manufactures, sells, and services thermal processing equipment and related controls for use by semiconductor manufacturers, and in electronics, automotive, and other industries; and Material and Substrate - it produces consumables and machinery for lapping (fine abrading) and polishing of materials, such as sapphire substrates, optical components, silicon wafers, numerous types of crystal materials, ceramics and metal components.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.